30 Results for "

HPV16

" in MedChemExpress (MCE) Product Catalog:
Products (30)

30 Results for "HPV16" in MCE Product Catalog:

  • Targets Recommended:
4
4 Cited Publications
Cat. No.: HY-136465
CAS No.: 570390-00-0
Purity:  99.78%
Research Areas:  

Infection

A2ti-1 is a selective and high-affinity annexin A2/S100A10 heterotetramer (A2t) inhibitor with an IC50 of 24 μM . A2ti-1 specifically disrupts the protein-protein interaction (PPI) between A2 and S100A10. A2ti-1 prevents human papillomavirus type 16 (HPV16) infection .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-136466
CAS No.: 482646-13-9
Purity:  99.27%
Research Areas:  

Infection

A2ti-2 is a selective and low-affinity annexin A2/S100A10 heterotetramer (A2t) inhibitor with an IC50 of 230 μM . A2ti-2 specifically disrupts the protein-protein interaction (PPI) between A2 and S100A10. A2ti-2 prevents human papillomavirus type 16 (HPV16) infection .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-114698
CAS No.: 1429192-00-6
Purity:  99.17%
Synonyms: RN 1-001
Research Areas:  

Infection

Retro-2 cycl (RN 1-001) is a retrograde transport inhibitor with antiviral activity. Retro-2 cycl (RN 1-001) inhibits JCPyV and HPV16 pseudoviruses, with an IC50 of 54 μM and 160 μM respectively .
loading...
    loading...
Cat. No.: HY-P1907
CAS No.: 151812-18-9
Target:  

HPV

Research Areas:  

Cancer

Human Papillomavirus (HPV) E7 protein (49-57) is a cytotoxic T lymphocyte (CTL) epitope peptide derived from HPV16 E7 protein (sequence: RAHYNIVTF). Human Papillomavirus (HPV) E7 protein (49-57) induces E749-57-specific CTL responses. Human Papillomavirus (HPV) E7 protein (49-57) can be used for the research of cervical cancer .
loading...
    loading...
Cat. No.: HY-P1778A
Target:  

HPV

Research Areas:  

Infection

HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) TFA is immunogenic in cervical carcinomas .
loading...
    loading...
Cat. No.: HY-P5407
CAS No.: 798569-33-2
HD5 is an innate immune effector peptide and SARS-CoV Inhibitor. HD5 binds to the ligand-binding domain of angiotensin-converting enzyme-2 (ACE2) via multiple hydrogen bonds to competitively block the receptor, shielding it from viral recognition. HD5 can be used for the research of COVID-19, HPV16 infection, epithelial ovarian cancer, small-cell lung cancer, and colon cancer .
loading...
    loading...
Cat. No.: HY-P1778
CAS No.: 160212-93-1
Target:  

HPV

Research Areas:  

Infection

HPV16 E7 (86-93) is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) is immunogenic in cervical carcinomas .
loading...
    loading...
Cat. No.: HY-163901
CAS No.: 945142-65-4
Target:  

HPV Apoptosis

Research Areas:  

Infection Cancer

E6-272 is a human papillomavirus 16 (HPV 16) inhibitor. E6-272 induces Apoptosis. E6-272 inhibits the proliferation of HPV-positive cells. E6-272 can be used in the research of cervical cancer .
loading...
    loading...
Cat. No.: HY-P5694
Target:  

HPV Parasite

Research Areas:  

Infection

Human α-defensin 5 is an antiviral peptide. Human α-defensin 5 blocks infection of non-enveloped viruses, including AdV, HPV, and polyomaviruses (IC50: 0.6-1.25 μM for HPV16). Human α-defensin 5 can bind to the viral capsid and blocks escape of the virus from the endosome. Human α-defensin 5 increases HIV binding to the cell surface. Human α-defensin 5 also has parasiticidal activity .
loading...
    loading...
Cat. No.: HY-P1881
CAS No.: 160040-04-0
Target:  

HPV

Research Areas:  

Cancer

HPV16-E711-20 epitope is a well-known HLA-A *0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. HPV16 CTL epitopes may be good candidates for the development of an effective peptide-based antitumor vaccine .
loading...
    loading...
Cat. No.: HY-P4088
CAS No.: 850859-24-4
Target:  

Peptides

Research Areas:  

Cancer

LyP-2 is a peptide that homes to tumor lymphatics. LyP2 homes to lymphatics of C8161 melanomas and cervical carcinomas and K14-HPV16 skin, but not to MDA-MB435 tumors, showing heterogeneity in the molecular markers of tumor cells and lymphatics .
loading...
    loading...
Cat. No.: HY-P10428
Target:  

HPV

Research Areas:  

Infection

E6AP-mimicking peptide (compound 13) is a high-affinity, selective, irreversible and potent peptide-based covalent HPV16 E6 inhibitor targeting the 16E6 oncoprotein using a cysteine-reactive acrylamide warhead. E6AP-mimicking peptide has a Ki of 17 nM. E6AP-mimicking peptide targets all residues appearing in the binding pocket of E6 to disrupt the binding interface of 16E6 and E6AP. E6AP-mimicking peptide selectively binds and crosslinks to MBP-16E6 in PBS or a protein mixture .
loading...
    loading...
Cat. No.: HY-156584
CAS No.: 1626364-18-8
Target:  

Endogenous Metabolite

Research Areas:  

Infection

ODE-Bn-PMEG is an antiviral compound with strong inhibitory activity against HPV-11, -16, and -18. ODE-Bn-PMEG effectively reduced transient amplification of viral DNA in transfected cells at concentrations well below its cytotoxic levels. ODE-Bn-PMEG showed increased uptake in human foreskin fibroblasts and was able to be efficiently converted to the active antiviral metabolite PMEG diphosphate in vitro. The P-chiral enantiomer of ODE-Bn-PMEG showed comparable antiviral activity, indicating its potential application against multiple HPV types. ODE-Bn-PMEG is a promising candidate for local inhibition of HPV-16, HPV-18, and other high-risk types .
loading...
    loading...
Cat. No.: HY-N20712
CAS No.: 59632-76-7
Anisomelic acid is a human papillomavirus HPV16 E6 and HPV E7 depletor . Anisomelic acid directly interacts with HPV16 E6, promotes its ubiquitination and proteasomal degradation by recruiting E3 ubiquitin ligase, downregulates E6 and facilitates E7 degradation. Anisomelic acid induces endogenous mitochondrial apoptosis, activates caspase-3, causes cleavage of PARP, and triggers p53-independent endogenous apoptosis by depleting cIAP2. Anisomelic acid can be used in research related to HPV-positive cancers and cervical cancer .
loading...
    loading...
Cat. No.: HY-P89419

Host:  

Rabbit

Application:  

WB, IHC-P, IHC-F, FC, IF-Tissue

Reactivity:  

Virus

loading...
    loading...
Cat. No.: HY-P89420

Host:  

Rabbit

Application:  

WB, IHC-P, IHC-F, FC, IF-Tissue

Reactivity:  

Virus

loading...
    loading...
Cat. No.: HY-P5407A
HD5 TFA is an innate immune effector peptide and SARS-CoV Inhibitor. HD5 TFA binds to the ligand-binding domain of angiotensin-converting enzyme-2 (ACE2) via multiple hydrogen bonds to competitively block the receptor, shielding it from viral recognition. HD5 TFA can be used for the research of COVID-19, HPV16 infection, epithelial ovarian cancer, small-cell lung cancer, and colon cancer .
loading...
    loading...
Cat. No.: HY-P72259
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: E7; Protein E7
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P72260
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: E6; Protein E6
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700914
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuHLA-A*0201 HPV16 E6 complex Protein
Species:  
Source:  
loading...
    loading...